MLA Diagnostics is pleased to announce our success in gaining the MIT R&D samenwerkings project funding. We will collaborate with the top-level diagnostics specialists, -Pathologie DNA, in a research project to improve melanoma diagnostics and prognostics.
This month, MLA Diagnostics was selected as a finalist in the Academic Startup Competition 2020. 20 ground-breaking innovations in various fields were selected based on their value proposition, the innovative character of the technology involved, the potential of their business and profit model, and the startup team composition. MLA Diagnostics is pleased to be competing to […]
MLA Diagnostics has recently received EIT funding from the Headstart program. With this funding the company will boost development the company’s Quality and Regulatory strategy.
LAB1891 and UtrechtInc will partner up to support 3 early stage startups selected by MSD to help innovation in their focus area. The programme provided coaching, workshops and access to a global network of expertise. MLA Diagnostics gained valuable clinical insights into pharma drivers and interests in biomarker applications in general, companion diagnostics, predictive biomarkers and personalised medicine.
The Mkb-innovatiestimulering Regio en Topsectoren (MIT) stimulates innovation in SMEs to align project with the top sectors. MLA Diagnostics received funding for a feasibility project to continue assay development and validation.